NanoEcho competitors & alternatives

iSono HealthHealthtechUnited States

63% match

Healthtech

iSono Health, Inc. specializes in automated breast imaging technology and provides diagnostic tools such as its FDA-cleared ATUSA system.

Smart Health Diagnostics CoHealthcare DiagnosticsUnited States

61% match

Healthcare Diagnostics

Smart Health Diagnostics Co. operates as a healthcare diagnostics holding company that oversees specialized portfolio businesses focused on pathology, oncology, and vascular diagnostics. The company provides slide-free digital pathology technology through its MUSE microscopy system and offers vascular diagnostic tools like SmartVascular Dx to detect vascular inflammation for clinicians and healthcare systems.

Non-profit Medical Technology

One Heart Health develops cost-effective medical technologies, including mobile screening tools and a proprietary app, to enable early diagnosis of congenital heart disease in children living in low-resource regions globally. The organization partners with local programs to facilitate screenings and connect affected children with life-saving cardiac surgeries.

Healthtech

Clarapath, Inc. is a U.S. medical-technology company developing robotic automation systems for anatomical pathology and histology workflows, including tissue processing and slide preparation. Its products are intended for hospital, clinical, and pathology laboratories to improve the efficiency and consistency of diagnostic specimen preparation.

CELLBXHEALTH PLCCLBX · BiotechGuildford, United Kingdom

60% matchPublic

Biotech

CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.

Medical - Diagnostics & Research

Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.

Healthcare

Deepecho is a healthtech company headquartered in Rabat, Morocco, that develops high-performance deep learning algorithms to democratize quality ultrasound diagnostics and improve child healthcare.

Healthcare

PD Theranostics, Inc. (operating as United Theranostics) provides molecular imaging and precision radiopharmaceutical therapy for cancer patients, specializing in treatments for prostate cancer, neuroendocrine tumors, and thyroid cancer. The company utilizes advanced diagnostics such as PET and SPECT scans combined with targeted radiopharmaceuticals to deliver personalized, outpatient treatment plans. Additionally, they participate in clinical trials and collaborate with referring providers to offer innovative cancer care options.

Scandinavian ChemoTech BCMOTECB · Health CareSweden

64% matchPublic

Similar health care company

Scandinavian ChemoTech AB develops and markets medical technology products for tumor treatment in humans and animals. Its proprietary Tumour Specific Electroporation (TSE) platform and IQwave system use targeted electric pulses to enhance the efficacy of low-dose chemotherapy while preserving healthy tissue.

PET/CT IQ Technology, LLCHealthcareUnited States

63% matchPrivate

Healthcare

PET/CT IQ Technology, LLC (operating as PET Imaging Institute of South Florida) provides advanced PET/CT medical imaging and diagnostic scanning services. The company serves patients and physicians in South Florida by offering specialized cancer detection, staging, and treatment planning scans.

FluoGuideFLUO · Health CareDenmark

63% matchPublic

Similar health care company

FluoGuide is a biotechnology company that develops products for precision cancer surgery to improve patient outcomes. Its lead product, FG001, illuminates cancerous tissue during procedures to help surgeons perform more precise operations and reduce cancer recurrence.

DoMore DiagnosticsHealth careNorway

63% match

Similar health care company

DoMore Diagnostics develops artificial intelligence technology for digital pathology and cancer diagnostics, aiming to personalize cancer treatment, improve patient care, and support drug development. The company offers products such as Histotype Px® Colorectal to provide precise cancer prognosis and reduce over- and undertreatment for patients.